{{Rsnum
|rsid=2257401
|Gene=CYP3A7
|Chromosome=7
|position=99709062
|Orientation=plus
|GMAF=0.2686
|Gene_s=CYP3A7,CYP3A7-CYP3AP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 12.3 | 87.7
| HCB | 11.1 | 46.7 | 42.2
| JPT | 0.0 | 50.0 | 50.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.1 | 46.7 | 42.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2257401
|Name_s=CYP3A7:1226C>G;T409R
|Gene_s=CYP3A7, CYP3A, CYP3A5P1
|Feature=Exon/NonSyn, Intron, Intron
|Evidence=PubMed ID:15903124
|Annotation=This variant is the defining SNP for CYP3A7*2 which has increased catalytic acitivity compared to wild type.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162355713
}}

{{PMID Auto
|PMID=17559345
|Title=Screening for SNPs and haplotypes in the CYP3A7 gene in Chinese populations.
}}

{{GET Evidence
|gene=CYP3A7
|aa_change=Arg409Thr
|aa_change_short=R409T
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2257401
|overall_frequency_n=8195
|overall_frequency_d=10758
|overall_frequency=0.761759
|n_genomes=46
|n_genomes_annotated=0
|n_haplomes=74
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|nblosum100=3
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}